home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Not Losing Sleep Over The Orexins

 
  February, 7 2007 9:32
your information resource in human molecular genetics
 
     
A study to be published in the February 2007 issue of Nature Medicine reveals a new method of promoting sleep by blocking a certain type of protein receptor. The proteins -- known as orexins -- are found in the brain and are important to keep you awake.

Orexins gained notoriety after the discovery that the brains of people with narcolepsy -- a condition in which patients suddenly and unexpectedly may fall sleep -- lack these molecules. They were not considered to be good targets to promote sleep in insomniacs, as people with narcolepsy also experience other problems such as cataplexy -- loss of muscle tone.

The new study, by François Jenck and colleagues, shows that blocking the orexin receptors encourages sleep without cataplexy in rats, dogs and humans. Their blocker is more efficient and has less secondary effects than other sleep-promoting agents, pointing to the orexin receptors as suitable targets for the development of new hypnotic compounds.

Author contact:

François Jenck (Actelion Pharmaceuticals Ltd, Allschwil, Switzerland)
E-mail: francois.jenck@actelion.com

Abstract available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.